A phase I/II study of pembrolizumab in combination with nab-paclitaxel in patients with unresectable stage III or stage IV non small-cell lung carcinoma (NSCLC). (2021) - Nassabein, Rami; Gaudreau, Pierre-Olivier; Belkaid, Wiam; Florescu, Marie; Blais, Normand